According to Alnylam Pharmaceuticals 's latest financial reports the company's current earnings are $2.09 Billion USD. In 2023 the company made an earning of -$0.32 Billion USD, an increase over its 2022 earnings that were of -$0.98 Billion USD. The earnings displayed on this page is the company's Pretax Income.